Search
for
Sort by
Research 331–360 of 1000+
- New Modalities in the Treatment of Refractory Alopecia Areata
- Chemotherapy-Induced Alopecia by Docetaxel: Prevalence, Treatment and Prevention
- Subject Index
- Iron Chelators in the Management of Autoimmune-Induced Alopecia: A Focus on Hypoxia-Inducible Factor 1 Modulation and Hair Restoration
- Epidermal Stem Cells do not Communicate Through Gap Junctions
- Alopecia areata: What’s new in epidemiology, pathogenesis, diagnosis, and therapeutic options?
- Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Genetic Hair Disorders: A Review
- Expanding phenotype of hereditary fibrosing poikiloderma with tendon contractures, myopathy, and pulmonary fibrosis caused by FAM111B mutations: Report of an additional family raising the question of cancer predisposition and a short review of early-onset poikiloderma
- Treatment of Alopecia Areata With Topical Sensitizers
- Dermoscopy of alopecia areata in restrospective analysis
- Alopecia areata – Current understanding and management
- The Use of Imaging Techniques in the Diagnosis of Dermatoses of the Scalp
- Clinical Insights and Prognostic Factors in Frontal Fibrosing Alopecia and Lichen Planopilaris: A Retrospective Cohort Study
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- Frontal Fibrosing Alopecia and the Role of Cosmeceuticals in Its Pathogenesis
- The Effects of Environmental Pollutants and Exposures on Hair Follicle Pathophysiology
- Establishing the financial burden of alopecia areata and its predictors
- Review on Alopecia Areata in the Middle East and Africa: Landscape and Unmet Needs
- Genetic analysis of interleukin 18 gene polymorphisms in alopecia areata
- 40062 Mini pulse corticosteroid therapy with oral dexamethasone for moderate to severe alopecia areata: a multicentric study
- Patient-Reported Psychosocial Burdens and Quality of Life and Work Productivity Impacts Among Patients with Clinically Distinct Alopecia Areata Severity Profiles
- Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
- Topical and intralesional therapies for alopecia areata
- Contact dermatitis to Minoxidil
- Development of Clinician-Reported Outcome (ClinRO) and Patient-Reported Outcome (PRO) Measures for Eyebrow, Eyelash and Nail Assessment in Alopecia Areata
- Topical tofacitinib for the treatment of alopecia areata affecting facial hair
- Characterization of scalp, eyelash and eyebrow hair regrowth in patients with severe alopecia areata randomized to placebo in brave AA1 and brave AA2 trials
- Population exposure–response analysis of the effect of ritlecitinib on eyebrow assessment and eyelash assessment in patients with alopecia areata